Botox Rival Stays on U.S. Market After Court Order; Evolus Rises

Evolus Inc. rose after its rival to the Botox wrinkle treatment was allowed to remain for sale in the U.S. temporarily while an appeals court considers staying an import ban won by AbbVie Inc.’s …
( read original story …)

---